CRISPR-Based CANDI Platform Detects 15 NTM Species in 3.5 Hours

Researchers from UNC and Tulane developed the CRISPR-based CANDI platform to rapidly detect 15 nontuberculous mycobacteria species from clinical samples with over 97% sensitivity, delivering results in about 3.5 hours compared to weeks needed for traditional methods. The platform integrates population genomics and microfluidic multiplexing and has secured a five-year grant for panel expansion and further clinical validation.

This Wire brief sits within Fusion42's coverage of Diagnostics.